Skip to main navigation Skip to search Skip to main content

Cost-effectiveness of Favipiravir in moderately to severely ill COVID-19 patients in the real-world setting of Saudi arabian pandemic referral hospitals

  • Ahmad Alamer
  • , Abdulaali R. Almutairi
  • , Shiraz Halloush
  • , Ahmed Al-jedai
  • , Ahmed Alrashed
  • , Mashael AlFaifi
  • , Yahya Mohzari
  • , Malak Almutairi
  • , Fatimah AlHassar
  • , Jude Howaidi
  • , Wedad Almutairi
  • , Ivo Abraham
  • , Nimer Alkhatib
  • Saudi Food Drug Authority
  • Applied Science Private University
  • Ministry of Health, Saudi Arabia
  • Alfaisal University
  • King Fahad Medical City
  • Almaarefa University
  • Imam Abdulrahman Bin Faisal University
  • University of Arizona
  • Al-Zaytoonah University of Jordan
  • PI pharma intelligence

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Cost-effectiveness of Favipiravir in moderately to severely ill COVID-19 patients in the real-world setting of Saudi arabian pandemic referral hospitals'. Together they form a unique fingerprint.
Sort by

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science